CSCI
Price
$2.66
Change
-$0.23 (-7.96%)
Updated
Dec 18, 04:56 PM (EDT)
JANX
Price
$55.03
Change
-$4.58 (-7.68%)
Updated
Dec 18, 04:59 PM (EDT)
79 days until earnings call
Ad is loading...

CSCI vs JANX

Header iconCSCI vs JANX Comparison
Open Charts CSCI vs JANXBanner chart's image
COSCIENS Biopharma
Price$2.66
Change-$0.23 (-7.96%)
Volume$288
CapitalizationN/A
Janux Therapeutics
Price$55.03
Change-$4.58 (-7.68%)
Volume$66.25K
CapitalizationN/A
CSCI vs JANX Comparison Chart
Loading...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSCI vs. JANX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCI is a Hold and JANX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CSCI: $2.89 vs. JANX: $59.61)
Brand notoriety: CSCI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSCI: 62% vs. JANX: 50%
Market capitalization -- CSCI: $8.64M vs. JANX: $3.5B
CSCI [@Biotechnology] is valued at $8.64M. JANX’s [@Biotechnology] market capitalization is $3.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSCI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CSCI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, CSCI is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSCI’s TA Score shows that 6 TA indicator(s) are bullish while JANX’s TA Score has 5 bullish TA indicator(s).

  • CSCI’s TA Score: 6 bullish, 2 bearish.
  • JANX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CSCI is a better buy in the short-term than JANX.

Price Growth

CSCI (@Biotechnology) experienced а +1.41% price change this week, while JANX (@Biotechnology) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

CSCI is expected to report earnings on Aug 08, 2024.

JANX is expected to report earnings on Mar 07, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($3.5B) has a higher market cap than CSCI($8.51M). JANX YTD gains are higher at: 455.545 vs. CSCI (55.382). CSCI has higher annual earnings (EBITDA): -9.89M vs. JANX (-83.88M). JANX has more cash in the bank: 658M vs. CSCI (20M). CSCI has less debt than JANX: CSCI (1.62M) vs JANX (23.4M). JANX has higher revenues than CSCI: JANX (13M) vs CSCI (7.6M).
CSCIJANXCSCI / JANX
Capitalization8.51M3.5B0%
EBITDA-9.89M-83.88M12%
Gain YTD55.382455.54512%
P/E RatioN/AN/A-
Revenue7.6M13M58%
Total Cash20M658M3%
Total Debt1.62M23.4M7%
FUNDAMENTALS RATINGS
CSCI: Fundamental Ratings
CSCI
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSCIJANX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 8 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEGAX13.88-0.08
-0.57%
abrdn Emerging Markets A
VIVIX67.60-0.42
-0.62%
Vanguard Value Index I
WCEAX17.55-0.12
-0.68%
Delaware Ivy Core Equity Fund Class A
LIRRX8.09-0.07
-0.86%
Lord Abbett International Value R3
WWSMX16.62-0.21
-1.25%
Westwood Quality SMidCap Fund Ultra

CSCI and

Correlation & Price change

A.I.dvisor tells us that CSCI and ARDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSCI and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-0.85%
ARDX - CSCI
31%
Poorly correlated
-13.54%
SLDB - CSCI
30%
Poorly correlated
-3.04%
JANX - CSCI
29%
Poorly correlated
-3.17%
FATE - CSCI
27%
Poorly correlated
-6.00%
SEER - CSCI
27%
Poorly correlated
-4.84%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-3.17%
VKTX - JANX
61%
Loosely correlated
-1.12%
DNLI - JANX
49%
Loosely correlated
-0.30%
LGND - JANX
41%
Loosely correlated
-1.56%
CDXS - JANX
38%
Loosely correlated
+0.36%
SKYE - JANX
38%
Loosely correlated
-0.91%
More